Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. J of Skin [Internet]. 2024 Jan. 16 [cited 2026 Apr. 30];8(1):s344. Available from: https://skin.dermsquared.com/skin/article/view/2350